Several studies have shown disturbances in the natural IL-6:sIL-6R:sgp130 buffer in pathologies such as infections or CRS (17), type 2 diabetes (18), cardiovascular diseases (19), and in chronic inflammation such as experimental atherosclerosis (20). This evidence concerns the gene IL6 and infection.